Dr. Donald Forthal, MD

• Pediatrics

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Los Angeles County - Usc Medical Center

  Fellowship Hospital, 1984

• Los Angeles County Harbor - Ucla Medical Center

  Residency Hospital, 1982

• San Francisco Gel Hospital

  Internship Hospital, 1980

• University Of California, Irvine School Of Medicine

  Medical School, 1979

• English

• French

• Virus control in vaccinated rhesus macaques is associated with neutralizing and capturing antibodies against the SHIV challenge virus but not with V1V2 vaccine-induced anti-V2 antibodies alone, 2021-02-03

• HIV vaccine candidate activation of hypoxia and the inflammasome in CD14+monocytes is associated with a decreased risk of SIVmac251acquisition, 2018-05-21

• Human immunodeficiency virus type-1 (HIV-1) evades antibody-dependent phagocytosis, 2017-12-27

• Passive immunization of macaques with polyclonal anti-SHIV IgG against a heterologous tier 2 SHIV: outcome depends on IgG dose, 2014-01-20

• Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques, 2010-10-03

• Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251acquisition, 2016-05-30

• Correction for Kibler et al., "Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC”, 2019-10-15

• Boosting of ALVAC-SIV vaccine-primed macaques with the CD4-SIVgp120 fusion protein, elicits antibodies to V2 associated with a decreased risk of SIVmac251acquisition, 2016-09-02

• Defense-in-depth by mucosally administered anti-HIV dimeric IgA2 and systemic IgG1 mAbs: Complete protection of rhesus monkeys from mucosal SHIV challenge, 2015-03-11

• Anti-HIV IgA Isotypes: Differential Virion Capture and Inhibition of Transcytosis are Linked to Prevention of Mucosal R5 SHIV Transmission, 2013-06-01

• Impact of Th1 CD4 Follicular Helper T Cell Skewing on Antibody Responses to an HIV-1 Vaccine in Rhesus Macaques Verma et al., 2020-02-28

• Antibody-Dependent Cellular Cytotoxicity (ADCC) in HIV Infection, 2018-11-13

• In vitroanti-HIV-1 activity of salicylidene acylhydrazide compounds, 2012-07-20

• Fc receptor-mediated antiviral antibodies, 2010-05-14

• HIV-1 Specific Antibody Titers and Neutralization among Chronically Infected Patients on Long-Term Suppressive Antiretroviral Therapy (ART): A Cross-Sectional Study, 2014-01-15

• A High Throughput Protein Microarray Approach to Classify HIV Monoclonal Antibodies and Variant Antigens, 2015-05-04

• Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques, 2015-08-03

• Heavily glycosylated, highly fit SIVMne variants continue to diversify and undergo selection after transmission to a new host and they elicit early antibody dependent cellular responses but delayed neutralizing antibody responses, 2008-08-04

• Vaccine Protection Against Acquisition of Neutralization-Resistant SIV Challenges in Rhesus Monkeys, 2012-01-04

• Low frequency of broadly neutralizing HIV antibodies during chronic infection even in quaternary epitope targeting antibodies containing large numbers of somatic mutations, 2015-12-31

• The Neonatal Fc Receptor (FcRn) Enhances Human Immunodeficiency Virus Type 1 (HIV-1) Transcytosis across Epithelial Cells, 2013-11-21

• Multimodality vaccination against clade C SHIV: partial protection against mucosal challenges with a heterologous tier 2 virus, 2014-09-20

• Broadly Neutralizing Human Anti-HIV Antibody 2G12 Is Effective in Protection against Mucosal SHIV Challenge Even at Low Serum Neutralizing Titers, 2009-05-15

• Association of VH4-59 Antibody Variable Gene Usage with Recognition of an Immunodominant Epitope on the HIV-1 Gag Protein, 2015-07-30

• HIV-1-Specific Antibody Response and Function after DNA Prime and Recombinant Adenovirus 5 Boost HIV Vaccine in HIV-Infected Subjects, 2016-08-08

• Immune Control of an SIV Challenge by a T Cell-Based Vaccine in Rhesus Monkeys, 2008-11-09

• A Human Antibody to the CD4 Binding Site of gp120 Capable of Highly Potent but Sporadic Cross Clade Neutralization of Primary HIV-1, 2013-08-26

• Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort study, 2023-08-07

• Diversity of antiviral IgG effector activities observed in HIV infected and vaccinated subjects, 2016-11-09

• Vaccine Induced Antibodies to the First Variable Loop of Human Immunodeficiency Virus Type 1 gp120, Mediate Antibody-Dependent Virus Inhibition in Macaques, 2011-10-27

• Functions of Antibodies, 2014-08-15

• Prolonged tenofovir treatment of macaques infected with K65R reverse transcriptase mutants of SIV results in the development of antiviral immune responses that control virus replication after drug withdrawal, 2012-07-17

• Proceedings of the Frontiers of Retrovirology Conference 2016, 2016-09-26